Skip to main content
. 2021 Oct 4;181(12):1668–1670. doi: 10.1001/jamainternmed.2021.5511

Table 2. Case Description and Clinical Coursea.

Patient No. Demographicsb Days to chest pain onset ECG Troponin I peak, ng/mL Evaluation of CAD LVEF on echo, % LOS, d
1 18-25 y, White man 7 Diffuse ST elevation 8.10 No CT evidence of CAD 55-60 3
2 18-25 y, White man 5 Inferolateral T wave inversion 8.87c No CT evidence of CAD 55-60 2
3 18-25 y, White man 5 Sinus tachycardia, no ischemic changes 1.59c No CT evidence of CAD 60-65 3
4 26-40 y, White man 3 No ischemic changes 2.50 Normal coronaries on cardiac catheterization 60-65 3
5 26-40 y, Hispanic man 3 Diffuse ST elevation 1.53c Normal coronaries on cardiac catheterization 55-60 1
6 26-40 y, White man 3 Diffuse ST elevation 17.12c Normal coronaries on cardiac catheterization 45, Global hypokinesis 3
7 18-25 y, White man 4 Diffuse ST elevation 5.00 No cardiac catheterization or CT performed 60-65 2
8 18-25 y, Hispanic man 2 Diffuse ST elevation 11.79 No CT evidence of CAD, MRI with myopericarditis 50-55 3
9 18-25 y, White man 3 No ischemic changes 7.37 No CT evidence of CAD 55-50 5
10 26-40 y, Hispanic man 1 No ischemic changes 2.98 Normal coronaries on cardiac catheterization 60-65 3
11 26-40 y, man, unknown ethnicity 3 Diffuse ST elevation 32.30 No CT evidence of CAD 55-60 3
12 26-40 y, White man 1 Diffuse ST elevation 6.28 No cardiac catheterization or CT performed 55-60 1
13 18-25 y, Hispanic man 3 Diffuse ST elevation 16.9 No cardiac catheterization or CT performed 30-35, Global hypokinesisd 3
14 18-25 y, White man 1 Diffuse ST elevation 15.9c No cardiac catheterization or CT performed 50-55 3
15 26-40 y, Asian man 2 Diffuse ST elevation 0.49c No CT evidence of CAD 50-55 3

Abbreviations: CAD, coronary artery disease; CT, computed tomography; ECG, electrocardiogram; Echo, echocardiogram; LOS, length of stay; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging.

a

To confirm myocarditis, the following criteria were used (1) symptoms consistent with myocarditis, (2) elevated troponin I level, (3) no evidence of obstructive coronary artery disease, and (4) no other identifiable cause.

b

Self-reported race and ethnicity from the electronic health record. To protect patient privacy, patient age was designated as either 18 to 25 or 26 to 40 years.

c

High-sensitivity troponin I values were converted from pg/mL to ng/mL (99th upper reference limit: 0.02 ng/mL).

d

LVEF recovered on a follow-up echocardiogram.